GDF15 drug shows promise in preventing heart failure related to T2DMA new experimental anti-obesity drug, Growth Differentiation Factor 15 (GDF15), improves diastolic heart function in mice with type 2...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events1 hour ago